Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification

References

• Karohl C, D'Marco Gascon L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol. 2011;7:567–577.
   PubMed Web of Science ®Google Scholar
• Tatsumoto N, Yamada S, Tokumoto M, et al. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. Am J Physiol Renal Physiol. 2015;309:F967–F979.
   PubMed Web of Science ®Google Scholar
• Cianciolo G, Capelli I, Cappuccilli M, et al. Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J. 2016;9:280–286.
   PubMed Web of Science ®Google Scholar
• Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014;307:F891–F900.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–325.
   PubMed Web of Science ®Google Scholar
• Gross P, Six I, Kamel S, et al. Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification. Circ J. 2014;78:2339–2346.
   PubMed Web of Science ®Google Scholar
• Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305:1119–1127.
   PubMed Web of Science ®Google Scholar
• Cannata-Andia JB, Martin KJ. The challenge of controlling phosphorus in chronic kidney disease. Nephrol Dial Transplant. 2016;31:541–547.
   PubMed Web of Science ®Google Scholar
• Sophie L, Hirokazu O, Lucie D, et al. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? Nephrol Dial Transplant. 2014;29:1275.
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154–1169.
   PubMed Web of Science ®Google Scholar
• Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994–999.
   PubMed Web of Science ®Google Scholar
• Un-Beom K, Jeonghun Y, Hoguen K, et al. Quantitative analysis of mTRAQ-labeled proteome using full MS scans. J Proteome Res. 2010;9:3750–3758.
   PubMed Web of Science ®Google Scholar
• Schulze WX, Usadel B. Quantitation in mass-spectrometry-based proteomics. Annu Rev Plant Biol. 2010;61:491–516.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li Y, Ding H, et al. Hydrogen peroxide prevents vascular calcification induced ROS production by regulating Nrf-2 pathway. Ren Fail. 2016;38:1099–1106.
   PubMed Web of Science ®Google Scholar
• Curtis CD, Davis RB, Ingram KG, et al. Chromatin-remodeling complex specificity and embryonic vascular development. Cell Mol Life Sci. 2012;69:3921–3931.
   PubMed Web of Science ®Google Scholar
• Davis RB, Curtis CD, Griffin CT. BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development. Development. 2013;140:1272–1281.
   PubMed Web of Science ®Google Scholar
• Fei F, Dewei C, Liming Y, et al. Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. Circ Res. 2013;113:986–996.
   PubMed Web of Science ®Google Scholar
• Li L, Liu D, Bu D, et al. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide. Biochim Biophys Acta (BBA)-Mol Cell Res. 2013;1833:1347–1355.
   PubMed Web of Science ®Google Scholar
• Shuwei W, Xiwu Z, Yang Y, et al. BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro. Eur J Cardio-Thorac Surg. 2015;47:439.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang M, Fang H, et al. The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression. ATVB. 2009;29:921.
   Google Scholar
• Chen M, Herring BP. Regulation of microRNAs by Brahma-related gene 1 (Brg1) in smooth muscle cells. J Biol Chem. 2013;288:6397–6408.
   PubMed Web of Science ®Google Scholar
• Cuadros M, Sanchez-Martin V, Herrera A, et al. BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines. Clin Transl Oncol. 2017;19:1010–1017.
   PubMed Web of Science ®Google Scholar
• Metzinger-Le Meuth V, Burtey S, Maitrias P, et al. microRNAs in the pathophysiology of CKD-MBD: biomarkers and innovative drugs. Biochim Biophys Acta Mol Basis Dis. 2017;1863:337–345.
   PubMed Web of Science ®Google Scholar
• Panizo S, Naves-Diaz M, Carrillo-Lopez N, et al. MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus. J Am Soc Nephrol. 2016;27:824–834.
   PubMed Web of Science ®Google Scholar
• Chen NX, Kiattisunthorn K, O'Neill KD, et al. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One. 2013;8:e64558.
   PubMed Web of Science ®Google Scholar
• Gretz N, Meisinger E, Strauch M. Partial nephrectomy and chronic renal failure: the 'mature' rat model. Contrib Nephrol. 1988;60:46.
   PubMedGoogle Scholar
• Niederhoffer N, Bobryshev YV, Lartaud-Idjouadiene I, et al. Aortic calcification produced by vitamin D3 plus nicotine. J Vasc Res. 1997;34:386–398.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Zheng PD, Oura H, et al. Animal model of adenine-induced chronic renal failure in rats. Nephron. 1986;44:230–234.
   PubMed Web of Science ®Google Scholar
• Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012;318:1040–1048.
   PubMed Web of Science ®Google Scholar
• Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370–1378.
   PubMed Web of Science ®Google Scholar
• Desjardins L, Liabeuf S, Renard C, et al. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int. 2012;23:2017–2025.
   PubMed Web of Science ®Google Scholar
• Schoppet M, Hofbauer LC, Brinskelle-Schmal N, et al. Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. J Clin Endocrinol Metab. 2012;97:E575.
   PubMed Web of Science ®Google Scholar